July 22, 2025 — Applus+ Laboratories is proud to announce that it has been officially recognized as an Authorized Test Lab (ATL) by the IEEE Standards Association (IEEE SA) to perform testing of medical devices according to the IEEE 2621 series of standards. This accreditation positions Applus+ Laboratories as the first global testing and certification company to achieve this prestigious status, joining a very short list of accredited laboratories—all of which focus exclusively on cybersecurity testing.
The IEEE 2621 standards address the cybersecurity of medical devices, initially targeting connected diabetes-related devices but designed to be extensible to all medical device categories. This comprehensive standard addresses the growing need for robust cybersecurity measures in the medical device industry, ensuring patient safety and data protection in an increasingly connected healthcare environment.
Being an IEEE SA Authorized Test Lab means Applus+ Laboratories can conduct rigorous testing required as part of the certification process to obtain the IEEE certification mark. This certification not only demonstrates compliance with cybersecurity best practices but also supports manufacturers in meeting regulatory requirements such as FDA approval.
The testing scope under IEEE 2621 includes vulnerability assessments, penetration testing, risk analysis, and verification of cybersecurity controls. These tests are critical to ensure that medical devices can withstand cyber threats while maintaining essential performance and safety.
While the IEEE 2621 accreditation highlights Applus+ Laboratories’ expertise in cybersecurity testing, our capabilities extend far beyond. Applus+ Laboratories offers a full suite of testing services for medical devices, including biomechanical, chemical, electrical safety, essential performance, and medical packaging testing. This integrated approach provides manufacturers with a one-stop solution for comprehensive device evaluation.
The IEEE 2621 series is based on internationally recognized standards and best practices for medical device cybersecurity, including the Common Criteria framework, an area where Applus+ Laboratories has extensive expertise. It was developed to address the increasing vulnerabilities in connected medical devices. For more information, visit the IEEE SA Medical Devices Cybersecurity page.
With this new accreditation, Applus+ Laboratories reinforces its commitment to supporting medical device manufacturers worldwide in delivering safe, secure, and reliable products. As the first global testing and certification company to earn this recognition, Applus+ Laboratories is uniquely positioned to help clients navigate the evolving landscape of medical device cybersecurity and regulatory compliance.
Applus+ uses first-party and third-party cookies for analytical purposes and to show you personalized advertising based on a profile drawn up based on your browsing habits (eg. visited websites). You can accept all cookies by pressing the "Accept" button or configure or reject their use. Consult our Cookies Policy for more information.
They allow the operation of the website, loading media content and its security. See the cookies we store in our Cookies Policy.
They allow us to know how you interact with the website, the number of visits in the different sections and to create statistics to improve our business practices. See the cookies we store in our Cookies Policy.
Based on your behavior on the website (where you click, how long you browse, etc.) we establish parameters and a profile for you to display ads that correspond to your interests. See the cookies we store in our Cookies Policy.